Antibody

Tau (HT-7)

Clonality: monoclonal
Host: Mouse
Methods: ELISA, IH, WB
Source: Innogenetics
cat# BR-001
distributed by Autogen Bioclear as 90222
References:
Siderowf, 2010
Clinton, 2010
Ueno, 2007
Oddo, 2005
Guo, 2006
Caccamo, 2006
Boekhoorn, 2006
Reactivity:
Reacts in: Bovine, Human
not rat

Immunogen/Epitope

immunogen = purified human tau; (epitope within aa 159-163)

Specificity

phosphorylated and non phosphorylated tau

Comments / Questions

No Available Comments

Make a comment or submit a question

To make a comment you must login or register.

References

Paper Citations

  1. . CSF amyloid {beta} 1-42 predicts cognitive decline in Parkinson disease. Neurology. 2010 Sep 21;75(12):1055-61. PubMed.
  2. . Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline. J Neurosci. 2010 May 26;30(21):7281-9. PubMed.
  3. . Novel conformation-sensitive antibodies specific to three- and four-repeat tau. Biochem Biophys Res Commun. 2007 Jun 29;358(2):602-7. PubMed.
  4. . Chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3046-51. PubMed.
  5. . M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron. 2006 Mar 2;49(5):671-82. PubMed.
  6. . Improved long-term potentiation and memory in young tau-P301L transgenic mice before onset of hyperphosphorylation and tauopathy. J Neurosci. 2006 Mar 29;26(13):3514-23. PubMed.

Further Reading

No Available Further Reading